Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data

<p>Abstract</p> <p>Background</p> <p>Epistasis is recognized as a fundamental part of the genetic architecture of individuals. Several computational approaches have been developed to model gene-gene interactions in case-control studies, however, none of them is suitable...

Full description

Bibliographic Details
Main Authors: Beretta Lorenzo, Santaniello Alessandro, van Riel Piet LCM, Coenen Marieke JH, Scorza Raffaella
Format: Article
Language:English
Published: BMC 2010-08-01
Series:BMC Bioinformatics
Online Access:http://www.biomedcentral.com/1471-2105/11/416
id doaj-1223753b355d40b09e0252f82c3914fe
record_format Article
spelling doaj-1223753b355d40b09e0252f82c3914fe2020-11-24T21:20:19ZengBMCBMC Bioinformatics1471-21052010-08-0111141610.1186/1471-2105-11-416Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored dataBeretta LorenzoSantaniello Alessandrovan Riel Piet LCMCoenen Marieke JHScorza Raffaella<p>Abstract</p> <p>Background</p> <p>Epistasis is recognized as a fundamental part of the genetic architecture of individuals. Several computational approaches have been developed to model gene-gene interactions in case-control studies, however, none of them is suitable for time-dependent analysis. Herein we introduce the Survival Dimensionality Reduction (SDR) algorithm, a non-parametric method specifically designed to detect epistasis in lifetime datasets.</p> <p>Results</p> <p>The algorithm requires neither specification about the underlying survival distribution nor about the underlying interaction model and proved satisfactorily powerful to detect a set of causative genes in synthetic epistatic lifetime datasets with a limited number of samples and high degree of right-censorship (up to 70%). The SDR method was then applied to a series of 386 Dutch patients with active rheumatoid arthritis that were treated with anti-TNF biological agents. Among a set of 39 candidate genes, none of which showed a detectable marginal effect on anti-TNF responses, the SDR algorithm did find that the rs1801274 SNP in the FcγRIIa gene and the rs10954213 SNP in the IRF5 gene non-linearly interact to predict clinical remission after anti-TNF biologicals.</p> <p>Conclusions</p> <p>Simulation studies and application in a real-world setting support the capability of the SDR algorithm to model epistatic interactions in candidate-genes studies in presence of right-censored data.</p> <p>Availability: <url>http://sourceforge.net/projects/sdrproject/</url></p> http://www.biomedcentral.com/1471-2105/11/416
collection DOAJ
language English
format Article
sources DOAJ
author Beretta Lorenzo
Santaniello Alessandro
van Riel Piet LCM
Coenen Marieke JH
Scorza Raffaella
spellingShingle Beretta Lorenzo
Santaniello Alessandro
van Riel Piet LCM
Coenen Marieke JH
Scorza Raffaella
Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data
BMC Bioinformatics
author_facet Beretta Lorenzo
Santaniello Alessandro
van Riel Piet LCM
Coenen Marieke JH
Scorza Raffaella
author_sort Beretta Lorenzo
title Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data
title_short Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data
title_full Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data
title_fullStr Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data
title_full_unstemmed Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data
title_sort survival dimensionality reduction (sdr): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data
publisher BMC
series BMC Bioinformatics
issn 1471-2105
publishDate 2010-08-01
description <p>Abstract</p> <p>Background</p> <p>Epistasis is recognized as a fundamental part of the genetic architecture of individuals. Several computational approaches have been developed to model gene-gene interactions in case-control studies, however, none of them is suitable for time-dependent analysis. Herein we introduce the Survival Dimensionality Reduction (SDR) algorithm, a non-parametric method specifically designed to detect epistasis in lifetime datasets.</p> <p>Results</p> <p>The algorithm requires neither specification about the underlying survival distribution nor about the underlying interaction model and proved satisfactorily powerful to detect a set of causative genes in synthetic epistatic lifetime datasets with a limited number of samples and high degree of right-censorship (up to 70%). The SDR method was then applied to a series of 386 Dutch patients with active rheumatoid arthritis that were treated with anti-TNF biological agents. Among a set of 39 candidate genes, none of which showed a detectable marginal effect on anti-TNF responses, the SDR algorithm did find that the rs1801274 SNP in the FcγRIIa gene and the rs10954213 SNP in the IRF5 gene non-linearly interact to predict clinical remission after anti-TNF biologicals.</p> <p>Conclusions</p> <p>Simulation studies and application in a real-world setting support the capability of the SDR algorithm to model epistatic interactions in candidate-genes studies in presence of right-censored data.</p> <p>Availability: <url>http://sourceforge.net/projects/sdrproject/</url></p>
url http://www.biomedcentral.com/1471-2105/11/416
work_keys_str_mv AT berettalorenzo survivaldimensionalityreductionsdrdevelopmentandclinicalapplicationofaninnovativeapproachtodetectepistasisinpresenceofrightcensoreddata
AT santanielloalessandro survivaldimensionalityreductionsdrdevelopmentandclinicalapplicationofaninnovativeapproachtodetectepistasisinpresenceofrightcensoreddata
AT vanrielpietlcm survivaldimensionalityreductionsdrdevelopmentandclinicalapplicationofaninnovativeapproachtodetectepistasisinpresenceofrightcensoreddata
AT coenenmariekejh survivaldimensionalityreductionsdrdevelopmentandclinicalapplicationofaninnovativeapproachtodetectepistasisinpresenceofrightcensoreddata
AT scorzaraffaella survivaldimensionalityreductionsdrdevelopmentandclinicalapplicationofaninnovativeapproachtodetectepistasisinpresenceofrightcensoreddata
_version_ 1726002791552385024